SEC Form 4 · accession 0000950138-17-000290
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael-Bryant Hicks
Officer — General Counsel
Period of report
Mar 7, 2017
Accepted (ET)
Mar 8, 2017 · 8:46 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Mar 7, 2017 | P | 290 | $50.35 | A | 8,639 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 406 shares acquired between April 6, 2016 and December 31, 2016 under the Mallinckrodt employee stock purchase plan.